Professional Documents
Culture Documents
6.1 Microbiology
6.1 Microbiology
MICROBIOLOGY
MICROBIOLOGY BACTERIAL ENVELOPE
• study of microorganisms which are large and diverse group • All concentric outer layers
of microscopic organisms that can occur as either single cell • Capsule
or in cluster arrangement including viruses which are • Outer Membrane
microscopic but acellular • Cell wall
• Cell Membrane
BACTERIOLOGY • Attachment protein
• Organ of locomotion
IINTRODUCTION TO BACTERIOLOGY
Capsule
MORPHOLOGY • Outermost layer, if present
• Encapsulated Bacteria:
Coccus • “Some Killers Have Pretty Nice Capsule”
• round/ circular • Streptococcus pneumoniae
• Klebsiella pneumoniae
• Haemophilus influenzae
• Pseudomonas aeruginosa
• Neisseria meningitidis
• Cryptococcus neoformans (fungi)
• Virulence factor (VF): K antigen → prevents phagocytosis
• Mucoid and slimy polysaccharide layer
• Identification: India ink stain
Outer membrane
• Major permeability barrier for Gram-negative bacteria
• Contains lipopolysaccharide (LPS) → endotoxin
Bacillus • Also present in Listeria spp. (Gram-positive) → not
• rod shaped converted to endotoxin (according to studies)
• Periplasmic Space: found between the outer membrane and
cell wall
Cell wall
• A.k.a. Peptidoglycan (PG) layer
• O antigen
• Present in all bacteria EXCEPT Mycoplasma spp.
Gram-Positive Gram-Negative
Gram reaction Blue/ violet Red/ pink
PG layer Thicker (7-8) Thinner (1-2)
Teichoic acid Present Absent
Spirochetes Periplasmic space Absent Present
• spiral shaped Toxin Produces Exotoxin Endotoxin
GRAM STAINING
Alcohol Decolorizer
Cell membrane
• Phospholipid bilayer embedded with protein
• Function: selective barrier for solutes, energy metabolism
(ATP production)
Attachment proteins
• Fimbriae – attachment to host cell
• Pili – attachment to another bacteria, conjugation (virulence Lag Phase
factor) • No replication, ↑ size, ↑ synthesis
Composition
Catalase (+) Catalase (-)
Chemically Defined Medium
• Exact composition is known
• For growth of photoautotrophs and chemoautotrophs
Staphylococcus Streptococcus
Complex/ Not Chemically Defined Medium
• Exact composition is not known
• For growth of most medically important bacteria
Staphylococcus
Tissue Culture Coagulase test
• For growth of viruses Mannitol Salt Agar (MSA)
Physical State
NEGATIVE β-hemolytic
Bacitracin Sensitivity
Novobiocin Sensitivity
GABHS GBS
Quellung Reaction
Optochin Sensitivity Streptococcus
SENSITIVE: RESISTANT:
Streptococcus Viridans
pneumoniae Streptococcus γ-hemolytic
Entamoeba histolytica
Presentation
• MOT: main source of water food contamination is the
• Cough for ≥ 2 weeks: most • Night sweats
important clinical findings • Easy fatigability
asymptomatic carrier who passes cysts
• Hemoptysis • Dyspnea • Presentation
• Weight loss • Chest/ back pain • Asymptomatic infection
• Amebic colitis/ dysentery (mild severe, “flask-shaped”
Diagnosis ulcer)
Sputum Microscopy • Extraintestinal infection (amebic liver abscess*, amebic
• Gold standard for fiagnosis hepatitis)
• 2 sputum samples: at least 1 out of 2 must be positive • Diagnosis: Stool exam (cysts, trophozoites)
Tuberculin Skin Test (TST)/ Purified Protein Derivative (PPD)/ • Treatment:
Mantoux Test • Asymptomatic infection: luminal amebicide
• Positive result: wheal or erythema ≥10mm after 48-72hours
• Amebic colitis/ dysentery: tissue + luminal amebicide
• International literatures: ≥15mm is positive, but note that in
endemic countries (Philippines) the cutoff is ≥10mm • Extraintestinal infection: tissue + luminal amebicide
Culture: Lowenstein-Jensen medium
Free living amebae
Cryptosporidium hominis
• Infect the intestine in immunocompromised persons (e.g.,
those with AIDS)
Mycobacterium avium-intracellulare complex • MOT: acquired from infected animal or human feces or form
• 2 combined species fecally contaminated food or water
• Presentation: causes TB in AIDS patients (AIDS-defining • Presentation: water diarrhea, which is mild and self-limited
illness: usually seen in patients with advanced HIV infection/ 91 to 2 weeks) in normal persons (prolonged in
AIDS) immunocompromised or very young or old individuals)
• Treatment: Macrolides + RE • Diagnosis: Stool exam (cysts)
• Treatment: no broadly effective therapy
Mycobacterium leprae
• Hansen’s bacillus Cyclospora cayetanensis
• Obligate intracellular parasite with predisposition to cooler • MOT: waterborne and foodborne infections from various
parts of the body (ex: skin, nerves) types of fresh produce (raspberries, mesclun, and basil)
• Isolation: armadillo foot pad • Presentation: diarrhea, anorexia, fatigue, and weight loss
• MOT: nasal discharge from untreated lepromatous leprosy • Diagnosis: stool exam (oocysts, acid-fast positive)
patients • Treatment: Trimethoprim-sulfamethoxazole (TMP-SMZ)
TOXICOSIS • Infections that extend deeper into the epidermis, also include
invasive hair and nail disease
Mycotoxicosis • Invoke inflammatory response: pain, welling, itching
• Poisonous toxins produced by fungi during normal metabolic • Causative agent: Dermatophytes
activity • Trichophyton spp.: affects skin, hair, nails
• Examples: • Microsporum spp.: affects skin, hair
• Aflatoxin • Epidermophyton spp.: affects skin, nails
• Produced by Aspergillus flavus Presentation: Dermatophytes/ Tinea/ Ringworm Infection
• Acquired via ingestion of improperly stored nuts/ Tinea capitis Scalp
grains Tinea barbae Beard
• Ergot Alkaloids Tinea corporis Trunk
• Produced by Claviceps purpurea Tinea imbricata Trunk/ limbs in concentric pattern
Tinea manuum Hand
Mycetismus Tinea unguium Nail
• Ingestion of poisonous mushroom Tinea cruris Groin “Jock itch”
• Example: Amanita phalloides → produces amatoxin which is Tinea pedis Foot “Athletes’ foot”
hepatotoxic
Subcutaneous mycoses
HYPERSENSITIVITY • Infections initially involving the dermis, subcutaneous tissue,
muscle, fascia
• Type I hypersensitivity • Superficial lesions extending along the lymphatics develop
• Fungal spores are allergenic later
• Presents as eczema (skin asthma), asthma, hay fever • MOT: skin penetration
• Sporotrichosis
MYCOSIS • Chromoblastomycosis
• Phaeohypomycosis
• Fungal infection • Mycetoma
• Superficial mycosis
• Cutaneous mycosis Sporothrix schenkii
• Subcutaneous mycosis • Thermal dimorphic fungi
• Systemic mycosis • Presentation: Sporotrichosis/ rose gardener’s disease
• Opportunistic mycosis • Nodular skin lesions → ulcer
• Diagnosis:
Superficial mycoses • KOH mount: conidia arranged in rosette-like clusters
• Treatment:
• KISS (potassium iodide saturated solution)
• Infections limited to the outermost layer of skin (stratum
• Amphotericin B: systemic infections
corneum of epidermis) and hair
• Oral itraconazole
• Do not invoke inflammatory response
• No pain
Chromoblastomycosis
• No swelling/ elevated skin lesions
• May be caused by one of the following dematiaceous fungi:
• No itching
• Phialophora verrucose
• Malassezia furfur
• Cladosporium carionii
• Exophiala werneckii
• Rhinocladiella aquaspera
• Trichosporon beigelii
• Fonsacea pedrosoi
• Piedraia hortai
• Fonsacea compacta
• Presentation: wart-like lesions with black dots extending
Malassezia furfur
along the lymphatics
• Thermal dimorphic fungi
• Treatment:
• Presentation: Tinea Versicolor/ Pityriasis Versicolor (an an)
• Itraconazole + Flucytosine
• Irregular patches of discrete, serpentine,
• Surgical excision
hypopigmented macules
• Diagnosis:
Phaeohypomycosis
• KOH mount: spaghetti and meatballs appearance
• May be caused by one of the following dematiaceous fungi:
• Wood’s UV lamp: pale greenish to yellow fluorescence
• Exophiala jeanselmei
over the lesion
• Philaphora richradsiae
• Treatment: Topical imidazole
• Bipolaris specifera
• Wangiella dermatitidis
Exophiala werneckii
• Cladophialophora bantiana
• Dematiaceous fungi – produces black pigment
• Presentation:
• Presentation: Tinea Nigra
• Solitary encapsulated cyst in the subcutaneous tissue
• Black macules usually seen at the palm
• Sinusitis
• Treatment: Topical Imidazole, Whitfield’s ointment®
• Brain abscess (C. bantiana)
(Salicylic acid + Benzoic acid)
• Treatment: Itraconazole/ Amphotericin B + Flucytosine
Piedraia hortai
Mycetoma
• Dematiaceous fungi
• Causative agents:
• Presentation: Black Piedra
• Bacteria: Actinomycetoma (Actinomadura madurae)
• Hard, black nodules on hair shart (scalp)
• Fungi: Eumycetoma
• Treatment:
• Pseudoallescheria boydii
• Shaving of affected hair
• Exophiala jeanselmei
• Topical salicylic acid
• Madurella mycetomatis
• Madurella gresia
Trichosporon beigelii
• Acromnium falciforme
• Presentation: soft, grayish white/ beige nodules on hair shaft
• Presentation: causes blockade of lymphatic vessels →
(scalp or axilla)
subcutaneous swelling → Madura foot
• Treatment:
• Treatment:
• Shaving of affected hair
• Ketoconazole (bacteria)
• Topical Imidazole: prevents infection
• Amputation (fungi)
Module 6 – Microbiology Page 15 of 32 RJAV 2022
Systemic mycoses Mucormycosis/ Zygomycosis
• Causative agent: bread molds (Glomerulomycta/
• Members are thermal dimorphic fungi Zygomycota)
• MOT: inhalational spores • Rhizopus spp.
• Presentation: asymptomatic to flu-like illness • Rhizomucor spp.
• Mainly differentiated by geographical location and risk factors • Cunninghamella spp.
Blastomycosis • Mucor spp.
North American Blastomycosis South American Blastomycosis / • Absidia spp.
Paracoccidioidomycosis • Presentation:
Blastomyces dermatitidis Paracoccidioides brasiliensis • Rhinocerebral mucormycosis: sinusitis
Presentation: Presentation: • Thoracic mucormycosis: pulmonary symptoms (cough),
• Pulmonary infiltrate: • Respiratory granuloma chest pain, SOB)
most common • Painful sores • Cutaneous mucormycosis: black eschar (invasive)
• Lesions of the bones, • Ulcers in the
• Treatment:
genitalia, CNS pharyngeal mucosa
Treatment: Itraconazole, Treatment: Itraconazole • Amphotericin B
Amphotericin B (severe) • Surgical debridement
• MOT: direct contact, sexual contact (sexually transmitted • MOT: inhalation or contact with contaminated water or saliva
disease), fomites, passage through infected birth canal • Formerly part of the Papovaviridae family (which no longer
• Formerly part of Papovaviridae family (which no longer exists)
exists) • Commonly associated with IC state (HIV/ AIDS)
• Morphology: small, naked capsid, DNA genome • Infections are ubiquitous
• Patho: infects the epithelial cells of the skin or mucous • Morphology: small naked capsid, DNA genome
membranes
• Presentation: different type of warts and cancer Polyomaviruses Diseases
JC Virus Progressive multifocal leukoencephalopathy
Skin Warts Common Less Common BK Virus Hemorrhagic cystitis in bone marrow
Cutaneous Syndromes transplant recipients
Skin Warts Ki and Wu virus Found in nasopharyngeal aspirates from
Plantar wart 1 2, 4 children with respiratory infections
Common wart 2, 4 1, 7, 26, 29 Merkel cell polyomavirus Merkel cell carcinomas
Flat wart 3, 10 27, 28, 41 SV40 Virus Progressive multifocal leukoencephalopathy
Epidermodysplasia 5, 8, 17, 20, 36 9, 12, 14, 15, 19, 21-25, 38,
verruciforms 46 • Diagnosis: confirmed by the presence of PCR amplified viral
Mucosal Syndromes DNA in cerebrospinal fluid and MRI or CT evidence of
Benign Head and Neck Tumors lesions
Laryngeal papilloma 6, 11 --- • Treatment: Cidofovir
Oral papilloma 6, 11 2, 16
Conjunctival 11 --- HEPATITIS VIRUSES
papilloma
Anogenital Warts
Condyloma 6, 11 1,2, 10, 16, 30, 44, 45
• MOT:
acuminatum • HAV, HEV: fecal-oral transmission
Cervical intraepithelial 16, 18 31, 33, 35, 39, 45, 51, 52, 56, • HBV, HCV, HDV: spread in blood, tissue and semen;
neoplasia, cancer 58, 59, 66, 68, 69, 73, 82 STDs (blood borne hepatitis)
(high-risk types) • Patho: liver disease defines symptoms
• Diagnosis: RT-PCR, ELISA
Association of Viruses with Human Cancers’ • Treatment: Antiviral drugs (refer to antiviral agents)
• Prevention: Vaccination, Hygiene
Virus Family Virus Human Cancer
Papillomaviridae Human Genital tumors Comparative Features of Hepatitis Viruses
papillomavirus Squamous cell carcinoma
Oropharyngeal carcinoma Feature Hepatitis A Hepatitis B Hepatitis Hepatitis D Hepatitis
Herpesviridae Epstein-Barr virus Nasopharyngeal carcinoma C E
Burkitt lymphoma Common “infectious” “serum” “Non-A, “Delta “Enteric
name Non-B agent” Non-A,
Hodgkin’s disease post- Non-B”
B-cell lymphoma transfusion
”
Human Kaposi sarcoma Virus Picornavirus Hepadnavirus Flavivirus; Viroid-like; Calicivirus
structure ; capsid, (+) ; envelope, envelope, envelope, -like;
Herpesvirus B Primary effusion lymphoma RNA DNA (+) RNA circular capsid, (+)
Hepadnaviridae Hepatitis B virus Hepatocellular carcinoma RNA RNA
Polyomaviridae Merkel cell virus Merkel cell carcinoma Trans- Fecal-oral Parenteral, Parenteral, Parenteral, Fecal-oral
mission sexual sexual sexual
Retroviridae Human T- Adult T-cell leukemia Onset Abrupt Insidious Insidious Abrupt Abrupt
lymphotropic virus Incubation 15-50 45-160 14-180+ 15-64 15-50
period
Human AIDS related malignancies (days)
immunodeficiency Severity Mild Occasionally Usually Co-infection Normal
severe subclinical; with HBV patients,
virus 70% occasionall mild;
Flaviridae Hepatitis C virus Hepatocellular carcinoma chronicity y severe; pregnant
super- women,
infection severe
• Diagnosis: PCR genome analysis of cervical swabs and with HBV
tissue specimens often
severe
• Treatment: Vaccines for HPV types Mortality <0.5% 1%-2% =4% High to very Normal
high patients,
1-2%;
Bivalent (Cervarix) Quadrivalent (Gardasil) Nine-Valent Vaccine
pregnant
(Gardasil-9) women,
• HPV types 16 and • HPV types 6, 11, • In 2014, the FDA 20%
18 16 and 18 approved a new Chronicity No Yes Yes Yes No
• Administered by • Administered nine-valent L1 VLP / carrier
intramuscular intramuscularly at vaccine that targets state
injection at months months 0, 2 and 6 HPV types 6, 11, Other None Primary Primary Cirrhosis, None
0, 1 and 6 • Approved for the ff: 16 and 18 (the disease hepatocellular hepato- fulminant
• The vaccine is - Vaccination of girls and types also targeted associa- carcinoma, cellular hepatitis
approved for women ages 9-26 years by the quadrivalent tion cirrhosis carcinoma,
cirrhosis
females 9-25 years of age to prevent genital HPV vaccine) as
Lab Symptoms Symptoms Symptoms Anti-HDV ---
of age warts and cervical cancer well as five
diagnosis and anti- and serum and anti- ELISA
caused by HPV types 6, additional HAV IgM levels of HCV
11, 16 and 18 oncogenic HPV HBsAg, ELISA,
- Vaccination of the same types (31, 33, 45, HBeAg, and genome
population to prevent 53 and 58) anti-HBc IgM testing
precancerous or • Administered
dysplastic lesions, intramuscularly at
including cervical AIS, months 0,2 and 6
CIN 2/3, VIN 2/3, VaIN • Approved for the
2/3 and CIN 1 same indications
- Vaccination of boys and as with the
men 9-26 years of age to quadrivalent
prevent genital warts (Gardasil) vaccine
caused by HPV types 6
and 11
- Vaccination of people 9-
26 years of age to prevent
anal cancer and
associated precancerous
Interpretation of Serologic Markers of Hepatitis B Virus
lesions due to HPV types Infection
6, 11, 16 and 18
Virus Disease
Orthreovirus Mild upper respiratory tract illness, GIT illness,
biliary atresia
Orbivirus/ Coltivirus Febrile illness with headache & myalgia
(zoonosis)
Rotavirus Gastrointestinal tract illness, respiratory tract
illness (?)
*Reovirus is the most common name of the family Reoviridae & for the
specific genus Orthoreovirus
RETROVIRUSES PARAMYXOVIRUSES
• MOT: direct person – to – person contact and respiratory • “supergroup” of at least 200 enveloped, segmented,
droplets negative-strand RNA viruses
• Only one serotype is known • Genus: Bunyavirus, Phlebovirus, Nairovirus, and Hantavirus
• Patho: infection of parotid gland, testes and CNS • Most are arboviruses (mosquito, ticks, or flies), except
• Presentation: Hantaviruses (rodents)
• Swelling of parotid gland (infectious parotitis) • Most are arboviruses except hantavirus (rodents)
• Swelling of other glands (epididymoorchitis, oophoritis, • Presentation: encephalitis; others cause hepatic necrosis or
mastitis, pancreatitis, and thyroiditis) hemorrhagic disease
• Meningoencephalitis • Diagnosis: RT-PCR
• Orchitis (testes) may result to sterility, but rare • Treatment: No specific therapy for infections
• Diagnosis: RT-PCR, immunoassays
• Treatment: symptomatic management Notable Bunyaviridae Genera
• Prevention: vaccine (MMR)
Paramyxoviruses: Parainfluenza Virus Bunyavirus Bunyamwera virus, Mosquito Febrile illness, Rodents,
California encephalitis, small
encephalitis rash mammals,
• MOT: person to person contact and respiratory droplets virus, La Crosse primates,
• Examples: Parainfluenza 1, 2, 3 and 4 virus, Oropouche marsupials,
virus; 150 birds
• Presentation: members
• Parainfluenza 1, 2, 3: laryngotracheobronchitis (croup) Phlebovirus Rift Valley fever Fly, Tick Sandfly fever, Sheep,
• Subglottal swelling virus, sandfly fever hemorrhagic cattle,
• “Seal bark” cough virus, Heartland fever, domestic
virus; 38 members encephalitis, animals
• Parainfluenza 4: mild URTI conjunctivitis,
• Diagnosis: RT-PCR myositis
• Treatment: Nairovirus Crimean –Congo Tick Hemorrhagic Hares,
hemorrhagic fever fever cattle, goats,
• Nebulized cold virus; 6 members seabirds
• Hot steam Uukuvirus Uukuniemi virus; 7 Tick --- Birds
members
Hantavirus Hantaan virus None Hemorrhagic Rodents
Paramyxoviruses: Respiratory Syncytial Virus (RSV) fever with renal
syndrome,
• Prevalent in young children/infants (≤2 years of age) adult
respiratory
• MOT: aerosols; direct contact distress
• Presentation: syndrome
• Bronchiolitis – infants Sin nombre None Hantavirus Deer mouse
pulmonary
• URTI with rhinorrhea – older children and adults syndrome,
• Diagnosis: RT-PCR shock,
• Treatment: pulmonary
edema
• Ribavirin – approved for treatment of infants
• Supportive (administered of O2, IV fluids, and nebulized
cold steam) ORTHOMYXOVIRUSES
Test Detects
Cell culture in 1° monkey kidney or Presence of virus; limited
Madin – Darby canine kidney cells cytopathologic effects
Hemadsorption to infected cells Presence of hemagglutinin protein
on cell surface
Hemagglutination Presence of virus in secretions
Hemagglutination inhibition Type and strain of influenza virus
or specificity of antibody
Antibody inhibition of Identification of influenza type and
Hemadsorption strain
Immunofluorescence, ELISA Influenza virus & antigens in
respiratory secretion or tissue
culture
Serology: Seroepidemiology
Hemagglutination inhibition,
hemadsorption inhibition, ELISA,
immunofluorescence, complement
fixation
Genomics: RT-PCR Identification of influenza type and
strain
• Treatment:
• Neuraminidase inhibitors (influenza A and B):
• Oseltamivir,
• Zanamivir
• Viral uncoating inhibitors (influenza A):
• Amantadine,
• Rimantadine
RHABDOVIRUSES
• Genus
• Vesiculovirus
• Lyssavirus (rabies and rabies–like viruses)
• Plant rhabdovirus group (unnamed)
• Other ungrouped rhabdoviruses of mammals, birds, IMMUNOLOGY
fish, and arthropods
• Most important pathogen: rabies virus IMMUNE RESPONSE
• MOT: transmitted in saliva and acquired from the bite of a
rabid animal • Response generated against a potential pathogen is called
• Morphology: Bullet-shaped, enveloped, negative-sense, an immune response
single-stranded RNA
• Patho: 1. Innate immunity
• Replicates in the muscle at the site of the bite • 1st line of defense
• Length of the Incubation Period is determined by the • Nonspecific to the invading pathogen
infection site to the CNS • Rapidly mobilized at the initial site of injection
• Incubation Period: 1-3 months (may be as short as 1 (immediate response)
week or more than a year) • Lacks immunologic memory (does not confer long
• Presentation: lasting protective immunity)
• Short prodromal phase
• 2-10 days 2. Adaptive immunity
• Symptoms: malaise, anorexia, headache, • 2nd defense system
photophobia, N&V, sore throat and fever • Specific for the pathogen
• Acute neurologic phase • Confers protective immunity to reinfection
• 2-7 days • Produces specific antibodies
Module 6 – Microbiology Page 22 of 32 RJAV 2022
• Branches: - Memory cells –
a. Humoral Immunity – mediated by B cells immunologic memory
(matures to become memory cells and plasma T lymphocytes (T cells):
cells) • CD4 + T cells (Helper T cells) Stimulation if the differentiation
and proliferation of B cells and
Function:
cytotoxic T cells
• Memory cells – immunologic memory • CD8 + T cells (Cytotoxic T Direct-attack cells that is
• Plasma cells – antibody production cells) capable of killing
b. Cellular-mediated immunity – mediated by T microorganisms and at times,
cells (helper T cells [CD4 + cells]; cytotoxic T cells even some of the body’s own
[CD8 + cells]) cells
• Suppressor T cells Capable of suppressing the
Innate Immunity Adaptive Immunity functions of both cytotoxic & T-
helper cells
- skin (epithelium) & mucous - Lymphoid cells (T cells & B
• Natural Killer cells Contribute to innate immunity by
membranes cells)
providing protection against
- phagocytic cells
viruses and Other intracellular
- NK cells
pathogens; play a critical role in
- Toll-like receptors
antibody-dependent cellular
- Cytokines
cytotoxic (ADCC)
- Complement system
1. Active immunity
• Contact with a foreign antigen (infectious agent)
• Individual actively produces antibodies (long lasting)
• Examples:
• Clinical or subclinical infection
• Immunization with live or killed organism
• Exposure to microbial products (toxins and
toxoids)
• Transplantation of foreign tissue
2. Passive immunity
• Administration of preformed antibodies
• Receives a large concentration of antibody immediately
(not long lasting)
• Useful when the px has no time to
• produce an antibody response
• Needle-prick injuries (without prior vaccination)
• Immunodeficiencies
• Post-exposure prophylaxis (e.g., Rabies)
Concentration of the different White Blood Cells in the blood IgG IgA IgM IgD IgE
Polymorphonuclear neutrophils 62.0% Heavy chain γ α µ δ ε
Polymorphonuclear eosinophils 2.3% symbol
Monocytes 0.4% Valence 2 4 5 2 2
Lymphocytes 30.0% MW 143,000 159,000 900,000 177,000 188,000
(Daltons) – – – –
Cells Functions 160,000 447,000 185,000 200,000
Serum conc 8-16 1.4 – 4.0 0.4 – 2.0 0.03 Trace
Neutrophils Phagocytosis; elevated during
(mg/mL) amounts
bacterial infection & acute
(adult)
inflammatory reactions
Serum t½ 21 7 7 2 2
Basophils Release of histamine
Percentage 80 15 5 0.2 0.002
Eosinophils Release of histamine; elevated
of total IG in
during parasitic infestation
serum
Monocytes Phagocytosis (mobile, periphery)
Complement Yes (+) No Yes (++) No No
Macrophages Phagocytosis (fixed, tissues);
fixing
antigen presentation
capacity
B lymphocytes Antigen presentation; matures
Placental + - - - -
(B cells) into:
transfer to
- Plasma cells – antibody
fetus
production
IgG Secreted by plasma cells in the blood. Condition T cell T cell B cell Serum Incidence
Able to cross the placenta into the fetus # function # antibodies
XLA, Bruton ✓ ✓ ↓↓ ↓ Rare
IgM May be attached to the surface of a B
syndrome
cell or secreted into the blood.
Responsible for early stages of immunity RAG1 or ↓↓ ↓↓ ↓↓ None Rare
RAG2 def
HYPERSENSITIVITY REACTIONS X-SCID ↓↓ ↓ ✓ ↓ Rare
XLP, Duncan ✓ ↓ ✓ ✓ or ↓ Rare
• Condition in which an exaggerated or augmented immune syndrome
response occurs that is harmful to the host X-hyper IgM ✓ ↓ ✓ IgM ↑↑ Rare
(CD40 or No IgG,
• Requires a presensitized stated (occur after the 2nd
CD40L IgE or IgA
encounter w/ that specific antigen)
mutation)
• Types:
Wiskott – ✓ ↓ ✓ ↓ Rare
• Antibody-mediated (type I, II, III)
Aldrich
• Cellular-mediated (type IV) syndrome
SCID: ADA ↓↓ ↓↓ ↓ ↓ Very rare
IMMUNODEFICIENCY DISEASES or PNP def
HLA def ↓ ↓ ✓ Poor Ag Very rare
1. Primary immunodeficiency response
• Defect is intrinsic to the cells of the immune system Ataxia ↓ ↓ ✓ IgE↓, IgA↓, Uncommon
• Genetically determined and inherited as a single gene defect telangiectasia IgG2↓
• Examples: DiGeorge ↓↓ ↓ ✓ IgG↓, IgE↓, Very rare
a. Phagocyte’s deficiency syndrome IgA↓
Chronic granulomatous disease (CGD) IgA ✓ ✓ ✓ IgA↓ common
• phagocytic cells do not kill microbes due to genetic deficiency
defect in cytochrome b-558
• defect in the ability of phagocytic cell to produce DRUGS/ AGENTS
peroxide and superoxide
ANTIBACTERIAL AGENTS
Chédiak-Higashi syndrome
• neutrophil granules fuse when the cells are I. Mechanisms of Antibacterial action
immature in the bone marrow → can phagocytose
bacteria but have greatly diminished ability to kill • Inhibition of cell wall synthesis
them • Inhibition of protein synthesis
• Inhibition of cell metabolism
Asplenic individuals • Inhibition of nucleic acid transcription and replication
• lack the filtration mechanism of spleen • Interactions with plasma membrane
macrophages (great risk factor for encapsulated
microorganisms) Inhibition of cell wall synthesis
b. Complement deficiencies A. BETA-LACTAM ANTIBIOTICS
Deficiencies of C1q, C1r, C1s, C4 and C2:
• susceptibility to pyogenic (pus-producing), PENICILLINS
staphylococcal and streptococcal infections
a. History
Deficiency of C3: • Discovered by Alexander Fleming
• higher incidence of pyogenic infections • Old: Penicillium notatum
• New: Penicillium chrysogenum
Defects of the properdin factors: • Isolated by Florey & Chain by freeze drying/ lyophilization
• also results in an increased susceptibility to
pyogenic infection infections b. Properties
• Contains an unstable bicyclic system
Deficiencies of C5 through C9: • Beta-lactam & Thiazolidine ring
• defective cell killing, which raises the susceptibility • Nucleus: 6-Aminopenicillanic acid (6-APA)
to disseminated infections by Neisser spp. • Precursors: Cysteine & Valine
• Shape: half open book
c. Lymphocyte Deficiencies
Deficiency in T cell infection c. Structure-activity relationship (SAR)
• Susceptible to opportunistic infections by: • Addition of electron withdrawing group – acid stability
1) Viruses, especially enveloped and non- • Addition of bulky groups – penicillin’s resistant
cytolytic viruses and recurrences of viruses • Addition of amino group – increase spectrum activity
that establish latent infections,
2) Intracellular bacteria d. Mechanism of action (MOA)
3) Fungi • Irreversibly inhibits transpeptidase by covalently binding to
4) Some parasites the serine residue of the active site thus inhibiting cell wall
synthesis
Deficiency in B cell function
• Complete lack of antibody production e. Classification of Penicillin
(hypogammaglobulinemia), inability to undergo
b. Properties 4. Ertapenem
• Contains an unstable bicyclic system • Benzoic acid contributes to high protein binding and prolongs
• Beta-lactam & Dihydrothiazine the half-life of the drug
• Nucleus: 7-Aminocephalosporanic acid (7-ACA)
• Precursors: Cysteine & Valein MONOBACTAM
• Better acid stability & resistance to B-lactamase
a. Properties
c. Mechanism of action (MOA) • Monocyclic B-lactams
• Irreversibly inhibits transpeptidase by covalently binding to • Inactive against gram positive. Moderate activity against a
the serine residue of the active site thus inhibiting cell wall narrow group of gram-negative bacteria, including P.
synthesis aeruginosa.
A. SULFONAMIDES TUBERCULOSIS
Amebicides that are effective against both intestinal & 1. Sodium Stibogluconate
extraintestinal forms of the disease: • MOA: inhibit phosphofructokinase
• aka Sodium antimony gluconate
1. Emetine and Dehydroemetine • Tx of Leishmaniasis
• alkaloids from Ipecac
• MOA: inhibit protein synthesis by preventing protein ANTHELMINTICS
elongation (protoplasmic poison)
• Also used for balatidial dysentery, fascioliasis, • are drugs that are capable of eliminating parasitic worms or
paragonimiasis helminths
• Limited use due toxic effects (GI, cardiovascular, • helminths: Cestodes (tapeworms), Trematodes (flukes),
neuromascular) Nematodes (roundworms
1. Cotrimoxazole 5. Albendazole
• Sulfamethoxazole + Trimethoprim • MOA: antimitotic/ antimicrotubule
• DOC for PCP • broad spectrum
1. Eflornithine 1. Praziquantel
• MOA: irreversible inactivation of Ornithine decarboxylase • MOA: increase Ca2+ membrane permeability → loss of Ca
• Tx of African sleeping sickness → contraction → paralysis → phagocytosis (DEATH)
• myelosuppressive (→ anemia, leukopenia, • Broad spectrum
thrombocytopenia) • Agent of choice for blood flukes (schistosomes)
2. Nifurtimox 2. Niridazole
• Tx of South American trypanosomiasis (T. cruzi) • for schistosomiasis
3. Benznidazole 3. Oxamniquine
• Tx of Chagas disease • MOA: inhibit DNA, RNA, Protein synthesis
• Tx of Schistosoma mansoni
4. Melarsoprol
• DOC for later stages of both forms of African 4. Bithionol
trypanosomiasis • Agent of choice for liver fluke (Fasciola hepatica) and lung
fluke (Paragonimus westermani)
5. Suramin
• Bisurea derivative containing six sulfonic acid groups Cestodes
• used as a long-term prophylactic agent for trypanosomiasis
(due to high protein binding, effect can last up to 3 months) 1. Niclosamide
• MOA: inhibit Oxidative phosphorylation
Toxoplasmosis
1. Sulfadiazine + Pyrimethamine
• most effective therapy
1. Amphotericin B 1. Flucytosine
• source: Streptomyces nodosus • Nucleoside antifungal (Pyrimidine antimetabolite)
• Prodrug of 5-flurouracil
2. Nystatin • Used in combination with Amphotericin B in Cryptococcal
• source: Streptomyces noursei meningitis
• DOC for candida infections • MOA: inhibits DNA & RNA synthesis
3. Natamycin 2. Griseofulvin
• source: Streptomyces natalensis • Source: Penicillum griseofulvum
• MOA: “mitotic spindle/microtubule poison” – inhibiting mitosis
• DOC for refractory ringworm infections of the body nails,
hair, feet
• Long duration of treatment (3-6 mos)
• Poor bioavailability
• Solutions:
• Micronized
• Taken with fatty food to increase abs
E. ECHINOCANDINS